BlackRock »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by BlackRock

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $86M 4.6M 18.67

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

BlackRock
Fairmount Funds Management
Hillhouse Capital Advisors
Baker Bros. Advisors
Rubric Capital Management
Braidwell
Morgan Stanley
State Street Corporation
Geode Capital Management
Nuveen Asset Management
Dimensional Fund Advisors
Rice Hall James & Associates
Parkman Healthcare Partners
Tang Capital Management
Millennium Management

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A